Anti-Cdk4 antibody [DCS-31]
| Name | Anti-Cdk4 antibody [DCS-31] |
|---|---|
| Supplier | Abcam |
| Catalog | ab6315 |
| Prices | $392.00 |
| Sizes | 100 µl |
| Host | Mouse |
| Clonality | Monoclonal |
| Isotype | IgG2a |
| Clone | DCS-31 |
| Applications | WB IP ICC/IF FC |
| Species Reactivities | Mouse, Rat, Human |
| Antigen | Recombinant full length protein (Human) |
| Description | Mouse Monoclonal |
| Gene | CDK4 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
ab6315 staining human MDA-MB-436 breast cancer cells by Flow Cytometery. Cells were treated with Trypsin/EDTA for 5 minutes, sample buffer prepared as 5%FCS in PBS and gating was done on live non apoptotic cells. The primary antibody diluted 1/500 and incubated with sample for 1 hour at 4°C. A FITC conjugated horse polyclonal to mouse IgG, diluted 1/200 was used as secondary
Product References
Development of a conditionally immortalized human pancreatic beta cell line. - Development of a conditionally immortalized human pancreatic beta cell line.
Scharfmann R, Pechberty S, Hazhouz Y, von Bulow M, Bricout-Neveu E, Grenier-Godard M, Guez F, Rachdi L, Lohmann M, Czernichow P, Ravassard P. J Clin Invest. 2014 May;124(5):2087-98.
Improved regenerative myogenesis and muscular dystrophy in mice lacking Mkp5. - Improved regenerative myogenesis and muscular dystrophy in mice lacking Mkp5.
Shi H, Verma M, Zhang L, Dong C, Flavell RA, Bennett AM. J Clin Invest. 2013 May;123(5):2064-77.
COUP-TFII controls mouse pancreatic beta-cell mass through GLP-1-beta-catenin - COUP-TFII controls mouse pancreatic beta-cell mass through GLP-1-beta-catenin
Boutant M, Ramos OH, Tourrel-Cuzin C, Movassat J, Ilias A, Vallois D, Planchais J, Pegorier JP, Schuit F, Petit PX, Bossard P, Maedler K, Grapin-Botton A, Vasseur-Cognet M. PLoS One. 2012;7(1):e30847.
In vitro cytotoxicity of Strobilanthes crispus ethanol extract on hormone - In vitro cytotoxicity of Strobilanthes crispus ethanol extract on hormone
Chong HZ, Rahmat A, Yeap SK, Md Akim A, Alitheen NB, Othman F, Gwendoline-Ee CL. BMC Complement Altern Med. 2012 Apr 4;12:35.
Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor - Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor
Ottewell PD, Woodward JK, Lefley DV, Evans CA, Coleman RE, Holen I. Mol Cancer Ther. 2009 Oct;8(10):2821-32.